Agios Pharmaceuticals, Inc.

JACOBS LEVY EQUITY MANAGEMENT, INC AGIO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

111,150

Value ($000)

3,026

Weight

0.0%

2020 Q2 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	3,026	0.0%	111,150	12/31/2025
2023 Q2	8/14/2023	4,095	0.0%	144,611	6/30/2023
2023 Q1	5/15/2023	14,116	0.1%	614,533	3/31/2023
2022 Q4	2/14/2023	13,162	0.1%	468,746	12/31/2022
2022 Q3	11/15/2022	13,765	0.1%	486,726	9/30/2022
2022 Q2	8/15/2022	8,802	0.1%	397,015	6/30/2022
2022 Q1	5/16/2022	13,561	0.1%	465,852	3/31/2022
2021 Q4	2/14/2022	10,125	0.1%	308,041	12/31/2021
2021 Q3	11/15/2021	13,963	0.1%	302,547	9/30/2021
2021 Q2	8/16/2021	12,015	0.1%	218,022	6/30/2021
2021 Q1	5/17/2021	10,497	0.1%	203,276	3/31/2021
2020 Q4	2/16/2021	5,052	0.0%	116,586	12/31/2020
2020 Q3	11/16/2020	4,770	0.0%	136,287	9/30/2020
2020 Q2	8/17/2020	2,364	0.0%	44,197	6/30/2020